PF - 00610355

DRUG2 trials

Sponsors

Pfizer

Conditions

Asthma, BronchialBronchial DiseasesLung DiseasesLung Diseases, ObstructivePulmonary Disease, Chronic ObstructiveRespiratory Tract Diseases

Phase 2

A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.

CompletedNCT00808288

PfizerLung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Start: 2010-03-31End: 2010-12-31Updated: 2019-02-06

A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects

WithdrawnNCT00830427

PfizerAsthma, Bronchial, Bronchial Diseases, Lung Diseases, Obstructive +1

Start: 2009-04-15End: 2009-12-31Updated: 2019-01-31